Factor Xa inhibitor (Corvas/Schering-Plough)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFactor Xa inhibitor (Corvas/Schering-Plough)
Drug Alias Nameoral anticoagulant (Corvas/Schering-Plough)Cordecin ASCVS-2371CVS-1496
ClassificationSmall molecules
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous ThrombosisMyocardial InfarctionAngina Pectoris +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDendreon San Diego Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDendreon San Diego LlcSchering-Plough Corp
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisMyocardial InfarctionAngina Pectoris +[6] 

Other Information

ATC CodeN/A
Related LinksN/A